Results 121 to 130 of about 33,506 (247)
A Study on Megaloblastic Anaemia and Pancytopenia
, 2019 Background: Megaloblastic Anaemia and pancytopenia are common medical problems, Vitamin B12and folic acid deficiencies are common causes for megaloblastic Anaemia.
Reddy, P Sashikanth, Srinivas, S
core
Pediatric Blood &Cancer, Volume 73, Issue 9, September 2026.ABSTRACT Background Childhood aplastic anemia (AA) is a rare disease, and both the disease itself and its treatment cause significant morbidity. We aimed to determine the contemporary incidence of childhood AA in Finland, to compare the clinical characteristics of AA against inherited bone marrow failure syndromes (IBMFS) and refractory cytopenia of ...
Lauri‐Matti Kulmala +8 more
wiley +1 more source
Rheumatologic Manifestations of Patients With Type B Insulin Resistance
Arthritis Care &Research, Volume 78, Issue 9, Page 1195-1200, September 2026.Objective The objectives of this study were to identify laboratory and clinical features associated with type B insulin resistance (TBIR), a rare condition caused by autoantibodies that inhibit the insulin receptor, most frequently occurring in the setting of systemic lupus erythematosus (SLE), and to increase awareness of this rare, life‐threatening ...
S. Amara Ogbonnaya +4 more
wiley +1 more source
American Journal of Hematology, Volume 101, Issue 9, Page 2214-2224, September 2026.ABSTRACT The predictive value of cytokines (CK) for malignancy‐associated adult hemophagocytic lymphohistiocytosis (M‐HLHa) remains uncertain. We evaluated a cytokine‐based Risk Score (RS) and the IL‐10/IL‐6 Ratio to predict M‐HLHa. Adult patients (n = 112) from the French HLH cohort (NCT02113917) with complete data for nine key HLH related CK measured
Coralie Bloch +47 more
wiley +1 more source
Pancytopenia: Clinical and Etiological Profile in Tertiary Care Hospital [PDF]
, 2019 BACKGROUND: Pancytopenia refers to reduction in all three formed elements of blood namely erythrocytes, leucocytes and platelets. It is not a disease entity per se but rather a triad of findings.
Nokchur Imchen,
core
American Journal of Hematology, Volume 101, Issue 9, Page 2258-2268, September 2026.ABSTRACT Quizartinib is a tyrosine kinase inhibitor with single agent activity in patients with relapsed or refractory (R/R) acute myeloid leukemia (AML) and has demonstrated efficacy in first‐line therapy when combined with intensive chemotherapy in both FLT3 ITD‐negative and positive AML.
Teresa Bernal +29 more
wiley +1 more source
DISTRIBUTION OF APLASTIC ANEMIA IN CHILDREN HAVING NEW-ONSET PANCYTOPENIA
Gomal Journal of Medical Sciences, 2017 Background: Pancytopenia is a common problem in clinical and haematological practice in pediatrics. A vast majority of diseases may present with pancytopenia. The clinical manifestations are usually attributable to anemia, leucopenia or thrombocytopenia,
Jahanzeb Khan Afridi +4 more
doaj
Real‐World Comparison of Dual Checkpoint Blockade and Immunotherapy Plus TKIs in Metastatic RCC
Cancer Medicine, Volume 15, Issue 9, September 2026.ABSTRACT Objectives To compare differences in clinical outcomes between dual immune checkpoint blockade and immunotherapy plus tyrosine kinase inhibitors (TKIs) as first‐line treatment for metastatic renal cell carcinoma in routine clinical practice. Patients and Methods Retrospective multicenter cohort study including 311 patients with International ...
Kojiro Ohba +19 more
wiley +1 more source
Myeloma Presenting with Pancytopenia: Our Experience from a Tertiary Care Center in South India
Journal of Applied HematologyBACKGROUND AND OBJECTIVES: Multiple myeloma commonly presents with anemia, but it is uncommon for patients to exhibit pancytopenia at initial presentation.
Shreya Patel, S. Josephine, Sri Gayathri
doaj +1 more source